The report provides a detailed analysis essential for establishing a Dronabinol production plant. It encompasses all critical aspects necessary for Dronabinol production, including the cost of Dronabinol production, Dronabinol plant cost, Dronabinol production costs, and the overall Dronabinol production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Dronabinol production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Dronabinol is a pharmaceutical form of tetrahydrocannabinol (THC) that is used mainly for medical purposes under prescription control. It is primarily prescribed to manage nausea and vomiting caused by cancer chemotherapy, especially in patients who do not respond well to standard antiemetic medicines.
It is also widely used to stimulate appetite in patients experiencing severe weight loss, especially those with HIV/AIDS or cancer undergoing chemotherapy. In some cases, dronabinol is used to help reduce chronic pain and discomfort, as well as to improve sleep and overall well-being in patients with severe illness. It is available in capsule and oral solution forms and is used under strict medical guidance due to its psychoactive properties. Additionally, it is used in clinical research to study cannabinoid effects on the nervous system and to support the development of related therapeutic drugs.
The primary factor that drives the market for Dronabinol is its usage as a drug for the treatment of chemotherapy-induced nausea and vomiting, which fuels its demand in the medical sector. Its application as a medication to stimulate appetite and promote weight gain in patients who have AIDS-related anorexia and chronic weight loss also boosts its demand in the pharmaceutical industry.
Its growing acceptance for off-label uses in managing conditions like chronic pain, multiple sclerosis, and sleep disorders further contributes to rising demand. Additionally, the shifting regulatory landscape favouring medical cannabis use, along with increasing patient awareness and physician acceptance, plays a key role in market expansion. Industrial Dronabinol procurement is influenced by factors such as the cost and quality of raw materials (including synthetic THC precursors), and compliance with stringent pharmaceutical regulations. Moreover, advancements in formulation technologies and the need for controlled logistics due to its classification as a regulated substance also impact its procurement processes.
Raw Material for Dronabinol Production
According to the Dronabinol production plant project report, the major raw materials for Dronabinol production includes cannabis plant (Cannabis sativa L.)
Production Process of Dronabinol
The extensive Dronabinol production cost report consists of the following industrial production process:
- Production via Chemical Synthesis: The production process of Dronabinol begins with extracting the natural cannabinoid mixture from the resinous parts of the Cannabis sativa L. plant. In this method, a solvent is used to pull out the main psychoactive component, which is delta9-THC, along with other cannabinoids from the dried flowering tops, leaves, or resin. Then, this crude extract is purified through careful chromatographic techniques to isolate pure delta9-THC, which involves separating it from impurities and unwanted plant materials. Finally, the isolated THC undergoes crystallisation or additional refinement steps to produce the high-purity Dronabinol in its stable oral capsule form as the desired product.
Dronabinol is a synthetic form of delta-9-tetrahydrocannabinol, which is the principal psychoactive constituent found in Cannabis sativa plants. It appears as a colourless to light yellow viscous oil at room temperature, and it is insoluble in water. It shows good solubility in organic solvents, such as ethanol, methanol, dimethyl sulfoxide, acetonitrile, and dimethylformamide. The molecular formula of the compound is C21H30O2, and its molecular mass is 314.46 g/mol. Its density is approximately 1.0536 g/cm³, and the melting point of the compound is below 25 degree Celsius. The boiling point is approximately 200 degree Celsius at 0.02 mmHg pressure, and it has a flash point of 14 degree Celsius, which makes it a combustible substance. The compound is highly lipophilic due to its hydrophobic nature, with water solubility of only about 2.8 mg/L at 23 degree Celsius. Dronabinol is formulated in sesame oil for pharmaceutical use due to its poor water solubility. It is recommended to handle the compound with appropriate safety precautions and avoid operating heavy machinery while under its influence.